237 related articles for article (PubMed ID: 15347178)
1. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?].
Siboni AH
Ugeskr Laeger; 2004 Aug; 166(32):2688; author reply 2688. PubMed ID: 15347178
[No Abstract] [Full Text] [Related]
2. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of primary biliary cirrhosis with ursodeoxycholic acid].
Lotterer E; Fleig WE
Z Gastroenterol; 1993 Oct; 31(10):633-5. PubMed ID: 8256481
[No Abstract] [Full Text] [Related]
4. [What is guaranteed in the therapy of primary biliary cirrhosis with bile acids?].
Leuschner U
Internist (Berl); 1990 Nov; 31(11):707-11. PubMed ID: 2289857
[No Abstract] [Full Text] [Related]
5. [Bronchiolitis obliterans with organizing pneumonia and primary biliary cirrhosis].
Montero C; Brage A; Rodríguez-Trigo G; Verea H
Med Clin (Barc); 2003 Jan; 120(1):37-8. PubMed ID: 12525305
[No Abstract] [Full Text] [Related]
6. Eosinophils and primary biliary cirrhosis-stoking the fire?
Neuberger J
Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
[No Abstract] [Full Text] [Related]
7. [Treatment of primary biliary cirrhosis. The effect of ursodeoxycholic acid is questioned now].
Broomé U
Lakartidningen; 2000 May; 97(21):2585-7. PubMed ID: 10881517
[No Abstract] [Full Text] [Related]
8. [Ursodeoxycholic acid in primary biliary cirrhosis. 1: Therapeutic approaches up to now and the rationale for treatment with ursodeoxycholic acid].
Eisenburg J; Eder M; Spengler U; Berg PA; Caselmann W; Mannes AG; Muntau A
Fortschr Med; 1988 Nov; 106(34):691-4. PubMed ID: 3061911
[No Abstract] [Full Text] [Related]
9. [Ursodeoxycholic acid in the treatment of primary biliary liver cirrhosis].
Poupon R
Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T5-8. PubMed ID: 8045357
[No Abstract] [Full Text] [Related]
10. Therapeutic trials in primary biliary cirrhosis.
Sherlock S
QJM; 1994 Nov; 87(11):701-3. PubMed ID: 7820545
[No Abstract] [Full Text] [Related]
11. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid.
Renou C; Bourlière M; Martini F; Ouzan D; Penaranda G; Larroque O; Harafa A; Igual JP; Calvet B; Sokolowsky S; Benderitter T; Halfon P
J Gastroenterol Hepatol; 2006 Apr; 21(4):781-2. PubMed ID: 16677173
[No Abstract] [Full Text] [Related]
12. Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines.
Tsochatzis EA; Gurusamy KS; Gluud C; Burroughs AK
J Hepatol; 2009 Dec; 51(6):1084-5; author reply 1085-6. PubMed ID: 19864037
[No Abstract] [Full Text] [Related]
13. Ursodeoxycholic acid therapy in primary biliary cirrhosis.
Podda M; Crosignani A; Battezzati PM; Quagliuolo M; Valsania C; Invernizzi P; Zuin M
Ital J Gastroenterol; 1996; 28(2):114-7. PubMed ID: 8782007
[TBL] [Abstract][Full Text] [Related]
14. Use of ursodeoxycholic acid in primary biliary cirrhosis.
Pham NT; Hart LL
Ann Pharmacother; 1993 Dec; 27(12):1472-4. PubMed ID: 8305782
[No Abstract] [Full Text] [Related]
15. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
[TBL] [Abstract][Full Text] [Related]
16. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study].
Leuschner U; Fischer H; Hübner K
Z Gastroenterol Verh; 1989 Jul; 24():133. PubMed ID: 2474926
[No Abstract] [Full Text] [Related]
17. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
Levy C; Angulo P
Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
[No Abstract] [Full Text] [Related]
18. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
[TBL] [Abstract][Full Text] [Related]
20. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
Yan G; Erik C; Gluud C
Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
